Growth Metrics

GoodRx Holdings (GDRX) Return on Capital Employed (2020 - 2026)

GoodRx Holdings' Return on Capital Employed history spans 6 years, with the latest figure at 7.82% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 254.0% to 7.82% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.82%, a 254.0% increase, with the full-year FY2025 number at 7.61%, up 278.0% from a year prior.
  • Return on Capital Employed hit 7.82% in Q4 2025 for GoodRx Holdings, up from 7.28% in the prior quarter.
  • Over the last five years, Return on Capital Employed for GDRX hit a ceiling of 7.82% in Q4 2025 and a floor of 10.41% in Q2 2021.
  • Historically, Return on Capital Employed has averaged 0.68% across 5 years, with a median of 0.83% in 2021.
  • Biggest five-year swings in Return on Capital Employed: surged 1273bps in 2022 and later plummeted -315bps in 2024.
  • Tracing GDRX's Return on Capital Employed over 5 years: stood at 0.88% in 2021, then plummeted by -87bps to 0.12% in 2022, then plummeted by -1637bps to 1.77% in 2023, then skyrocketed by 398bps to 5.28% in 2024, then soared by 48bps to 7.82% in 2025.
  • Business Quant data shows Return on Capital Employed for GDRX at 7.82% in Q4 2025, 7.28% in Q3 2025, and 7.55% in Q2 2025.